February 2025: Healthcare M&A Snapshot
- Eclipse Corporate Finance
- Mar 5
- 2 min read

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in February 2025 below.
Notable Sector Deals: February 2025
Liva Healthcare’s acquisition of Momenta
A complementary deal for Liva Healthcare with the acquisition of digital lifestyle service provider Momenta
Momenta provides digital and in-person healthy lifestyle programmes to the NHS and local authorities across the UK, for the prevention of chronic conditions such as type 2 diabetes
Liva is a digital health technology platform with human-led therapeutic intervention programmes for lifestyle-related chronic diseases
The deal will cement Liva’s position as one of the largest providers of healthy lifestyle programmes to the NHS and follows its latest funding round led by Danish family investment group, IBL Group
Acquisition of Hospital Services by Asker Healthcare Group
A strategic acquisition for Asker Healthcare Group, with the bolt-on of Belfast-based Hospital Services Limited (HSL)
HSL is a specialist distributor of diagnostic medical devices to public and private hospitals across RoI, Northern Ireland, and Great Britain
Asker Healthcare Group is a European consolidator of medical product businesses, completing 50 acquisitions since 2019
The transaction provides a successful exit for Foresight Group, after driving HSL’s growth to revenues of c.£60m since investing in 2015
The deal highlights continued activity in the medical products market, with large scale operators deploying buy and build strategies
Audiological Science MBO supported by YFM
Another successful healthcare deal for YFM, backing the management buy-out of Audiological Science with a £12.4m investment
Audiological Science provides hearing tests, hearing aids and a wider range of audiology services to both NHS and private-pay patients
As a specialist community-based provider, the business plays a crucial role in supporting the NHS in its ambition to take low-complexity ear care out of hospital settings, reducing waiting lists and freeing up hospitals to focus on more complex cases
The deal highlights continued private equity interest in high quality businesses providing community-based services to the NHS
Acquisition of Apple House by National Care Group
A further acquisition for specialist care consolidator, National Care Group, with the addition of specialist accommodation provider Apple House
Apple House operates across six locations in the Dorset area, offering personalised support for adults with learning disabilities and associated needs
The acquisition will strengthen National Care Group’s care provision in the region and allow collaboration with its existing services
Demand for high-quality, person-centred adult social care continues to grow, with providers focusing on expanding services to meet the needs of individuals, families, and commissioning bodies
Healthcare Market Activity: February 2025
Private Equity Activity
Sub-sector | Target | Acquirer / Investor | Exiting PE |
Clinical Services | Audiological Science | YFM | N/A |
Clinical Services | Momenta | Liva Healthcare(IBL Group) | N/A |
Medical Equipment | HSL | Asker Healthcare | Foresight |
Pharma | ALTURiX | Kelso Pharma (Apposite) | N/A |
Venture Capital Activity
Target | Description | Lead Investor | Investment |
CareLoop | Digital therapeutics for mental health | Praetura | £1.8m |
IQ Endoscopes | Single use, flexible endoscopes | BGF | £5.2m |
Level Zero Health | Remote hormone monitoring | Redalpine | £5.5m |
OrganOx | Medical technology used in organ transplants | HealthQuest Capital | $142m |
Pill Connect | Device to track medicine consumption | Praetura | N/D |